NOT FOR DISTRIBUTION
Header cover image

Market Cap

JP¥163.6b

Last Updated

2021/09/16 15:25 UTC

Data Sources

Company Financials +

Executive Summary

Kureha Corporation manufactures and sells functional materials, specialty chemicals, and plastics in Japan, Asia, Europe, and internationally. More Details


Snowflake Analysis

Flawless balance sheet with proven track record and pays a dividend.


Similar Companies

Share Price & News

How has Kureha's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 4023 is not significantly more volatile than the rest of JP stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: 4023's weekly volatility (5%) has been stable over the past year.


Market Performance


7 Day Return

1.7%

4023

3.4%

JP Chemicals

1.5%

JP Market


1 Year Return

65.9%

4023

28.0%

JP Chemicals

25.9%

JP Market

Return vs Industry: 4023 exceeded the JP Chemicals industry which returned 28% over the past year.

Return vs Market: 4023 exceeded the JP Market which returned 25.9% over the past year.


Shareholder returns

4023IndustryMarket
7 Day1.7%3.4%1.5%
30 Day10.0%11.8%9.3%
90 Day36.7%8.3%7.4%
1 Year70.7%65.9%30.5%28.0%28.6%25.9%
3 Year12.3%3.3%33.5%23.7%26.1%17.5%
5 Year154.1%123.5%93.5%73.0%73.4%54.2%

Long-Term Price Volatility Vs. Market

How volatile is Kureha's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Kureha undervalued compared to its fair value and its price relative to the market?

11.09x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: 4023 (¥8380) is trading above our estimate of fair value (¥6906.14)

Significantly Below Fair Value: 4023 is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: 4023 is good value based on its PE Ratio (11.1x) compared to the JP Chemicals industry average (12.9x).

PE vs Market: 4023 is good value based on its PE Ratio (11.1x) compared to the JP market (15.2x).


Price to Earnings Growth Ratio

PEG Ratio: 4023 is poor value based on its PEG Ratio (1.8x)


Price to Book Ratio

PB vs Industry: 4023's PB Ratio (0.9x) is in line with the JP Chemicals industry average.


Future Growth

How is Kureha forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?

6.1%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: 4023's forecast earnings growth (6.1% per year) is above the savings rate (0%).

Earnings vs Market: 4023's earnings (6.1% per year) are forecast to grow slower than the JP market (10.3% per year).

High Growth Earnings: 4023's earnings are forecast to grow, but not significantly.

Revenue vs Market: 4023's revenue (3.9% per year) is forecast to grow slower than the JP market (4.8% per year).

High Growth Revenue: 4023's revenue (3.9% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 4023's Return on Equity is forecast to be low in 3 years time (7.5%).


Past Performance

How has Kureha performed over the past 5 years?

11.8%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 4023 has high quality earnings.

Growing Profit Margin: 4023's current net profit margins (9.8%) are higher than last year (8.5%).


Past Earnings Growth Analysis

Earnings Trend: 4023's earnings have grown by 11.8% per year over the past 5 years.

Accelerating Growth: 4023's earnings growth over the past year (21.6%) exceeds its 5-year average (11.8% per year).

Earnings vs Industry: 4023 earnings growth over the past year (21.6%) underperformed the Chemicals industry 31.4%.


Return on Equity

High ROE: 4023's Return on Equity (8%) is considered low.


Financial Health

How is Kureha's financial position?


Financial Position Analysis

Short Term Liabilities: 4023's short term assets (¥83.0B) exceed its short term liabilities (¥41.2B).

Long Term Liabilities: 4023's short term assets (¥83.0B) exceed its long term liabilities (¥26.2B).


Debt to Equity History and Analysis

Debt Level: 4023's debt to equity ratio (13.9%) is considered satisfactory.

Reducing Debt: 4023's debt to equity ratio has reduced from 67.8% to 13.9% over the past 5 years.

Debt Coverage: 4023's debt is well covered by operating cash flow (121.1%).

Interest Coverage: 4023 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is Kureha current dividend yield, its reliability and sustainability?

2.03%

Current Dividend Yield


Upcoming Dividend Payment

TodaySep 16 2021Ex Dividend DateSep 29 2021Dividend Pay DateDec 02 202164 days from Ex DividendBuy in the next 12 days to receive the upcoming dividend

Dividend Yield vs Market

Notable Dividend: 4023's dividend (2.03%) is higher than the bottom 25% of dividend payers in the JP market (1.27%).

High Dividend: 4023's dividend (2.03%) is low compared to the top 25% of dividend payers in the JP market (2.96%).


Stability and Growth of Payments

Stable Dividend: 4023's dividends per share have been stable in the past 10 years.

Growing Dividend: 4023's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its low payout ratio (22.5%), 4023's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

3.4yrs

Average management tenure


CEO

Yutaka Kobayashi (76 yo)

no data

Tenure

Mr. Yutaka Kobayashi serves as the Chief Executive Officer and President of Kureha America, Inc., and Kureha Corporation. Mr. Kobayashi served as the President of Kobayashi Pharmaceutical Co Ltd. since Jun...


Leadership Team

Experienced Management: 4023's management team is considered experienced (3.4 years average tenure).


Board Members

Experienced Board: 4023's board of directors are considered experienced (3.7 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Kureha Corporation's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Kureha Corporation
  • Ticker: 4023
  • Exchange: TSE
  • Founded: 1944
  • Industry: Commodity Chemicals
  • Sector: Materials
  • Market Cap: JP¥163.558b
  • Shares outstanding: 19.52m
  • Website: https://www.kureha.co.jp

Number of Employees


Location

  • Kureha Corporation
  • 3-3-2, Nihonbashi-Hamacho
  • Chuo-ku
  • Tokyo
  • 103-8552
  • Japan

Listings


Biography

Kureha Corporation manufactures and sells functional materials, specialty chemicals, and plastics in Japan, Asia, Europe, and internationally. It operates through five segments: Advanced Materials, Special...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/09/16 15:25
End of Day Share Price2021/09/16 00:00
Earnings2021/06/30
Annual Earnings2021/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.